MedTrace Logo

Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery

NCT02709200 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-03-28

No results posted yet for this study

Summary

This is a prospective study looking at the effects of dexmedetomidine on pacemaker function in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass (CBP). For the purpose of the study, no change in intraoperative care will be dictated. The use of dexmedetomidine will be left up to the discretion of the treating physicians. The study will involve only the collection of data regarding the amplitude required to capture and specific demographics and intraoperative features including cross clamp time, time on CPB, and vasoactive agents that were and are being administered. In addition to these data, it will be noted whether dexmedetomdine was used or not and whether it is being administered on arrival to the CTICU.

Conditions

  • Congenital Heart Disease

Interventions

DRUG

Dexmedetomidine

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2019-03-11
Completion
2019-03-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02709200 on ClinicalTrials.gov